- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- January 2026
- 146 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- March 2024
- 110 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- May 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- October 2023
- 140 Pages
Global
From €3897EUR$4,450USD£3,383GBP
The Alli market is a segment of the anti-obesity drug industry. Alli is a weight loss aid that is available over-the-counter and is the only FDA-approved over-the-counter weight loss drug. Alli works by blocking the absorption of some of the fat from the food that is eaten. It is intended to be used in conjunction with a reduced-calorie, low-fat diet and regular exercise. Alli is marketed as a weight loss aid that can help people lose more weight than diet and exercise alone.
The Alli market is highly competitive, with many companies offering similar products. Some of the major players in the Alli market include GlaxoSmithKline, Novo Nordisk, Merck, and Pfizer. Other companies in the market include Allergan, Sanofi, and Johnson & Johnson. Show Less Read more